A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 339
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : UI
Long Form : uncertainty interval
No. Year Title Co-occurring Abbreviation
2019 A comprehensive study capturing vision loss burden in Pakistan (1990-2025): Findings from the Global Burden of Disease (GBD) 2017 study. GBD, VA, YLDs
2019 A Cost Analysis and Cost-Utility Analysis of a Community Pharmacist-Led Intervention on Reducing Cardiovascular Risk: The Alberta Vascular Risk Reduction Community Pharmacy Project (RxEACH). CV
2019 Accounting for long-term manifestations of Cryptosporidium spp infection in burden of disease and cost-of-illness estimations, the Netherlands (2013-2017). BOD, COI, DALY, YLDs, YLLs
2019 Adverse risk factor trends limit gains in coronary heart disease mortality in Barbados: 1990-2012. ADs, AMI, CHD, DPPs, SIDs
2019 Age-targeted tuberculosis vaccination in China and implications for vaccine development: a modelling study. NNV
2019 An exploration of the disease burden due to Cryptosporidium in consumed surface water for sub-Saharan Africa. DALYs, GloWPa-Crypto, QMRA
2019 Association of Adverse Effects of Medical Treatment With Mortality in the United States: A Secondary Analysis of the Global Burden of Diseases, Injuries, and Risk Factors Study. AEMT, GBD, ICD
2019 Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis. BSIs, DALYs, EARS-Net, EEA
2019 Burden and trend of diet-related non-communicable diseases in Australia and comparison with 34 OECD countries, 1990-2015: findings from the Global Burden of Disease Study 2015. DALYs, GBD, NCDs, OECD, PAF
10  2019 Cardiovascular mortality attributable to dietary risk factors in 51 countries in the WHO European Region from 1990 to 2016: a systematic analysis of the Global Burden of Disease Study. CVDs
11  2019 Cataract surgery for falls prevention and improving vision: modelling the health gain, health system costs and cost-effectiveness in a high-income country. ICER, NZ, QALYs
12  2019 Combining primary care surveillance and a meta-analysis to estimate the incidence of the clinical manifestations of Lyme borreliosis in Belgium, 2015-2017. CI, EM, LB
13  2019 Cost-Effectiveness Analysis and Stakeholder Evaluation of 2 Obesity Prevention Policies in Maine, US. QALYs, SNAP, SSB
14  2019 Cost-Effectiveness of Alirocumab: A Just-in-Time Analysis Based on the ODYSSEY Outcomes Trial. MI, QALY
15  2019 Cost-Effectiveness of the FDA Added Sugar Labeling to Reduce Cancer Burden in the United States (OR28-03-19). DiCOM, QALYs
16  2019 Diarrhoea deaths and disability-adjusted life years attributable to suboptimal breastfeeding practices in Nigeria: findings from the global burden of disease study 2016. DALYs
17  2019 Dietary and Weight Loss Benefits of a National Sugar-sweetened Beverage Health Warning Policy: A Microsimulation Analysis (OR28-02-19). SSBs
18  2019 Disease burden of varicella versus other vaccine-preventable diseases before introduction of vaccination into the national immunisation programme in the Netherlands. BCoDE, BOD, DALYs, NIPs
19  2019 Diseases, Injuries, and Risk Factors in Child and Adolescent Health, 1990 to 2017: Findings From the Global Burden of Diseases, Injuries, and Risk Factors 2017 Study. SDI
20  2019 Does infection with Chlamydia trachomatis induce long-lasting partial immunity? Insights from mathematical modelling. ---
21  2019 Effectiveness and cost-effectiveness of vaccination against herpes zoster in Canada: a modelling study. NNV, QALY
22  2019 Epidemiology and health-economic burden of urinary-catheter-associated infection in English NHS hospitals: a probabilistic modelling study. CAUTI, NHS, QALYs
23  2019 Estimated Global, Regional, and National Cardiovascular Disease Burdens Related to Fruit and Vegetable Consumption: An Analysis from the Global Dietary Database (FS01-01-19). CHD, CVD, PAF
24  2019 Estimated Global, Regional, and National Cardiovascular Disease Burdens Related to Fruit and Vegetable Consumption: An Analysis from the Global Dietary Database (FS01-01-19). CHD, CVD, PAF
25  2019 Estimating long-term tuberculosis reactivation rates in Australian migrants. TB
26  2019 Estimating the burden of dengue and the impact of release of wMel Wolbachia-infected mosquitoes in Indonesia: a modelling study. DALYs
27  2019 Estimating the total incidence of global childhood cancer: a simulation-based analysis. ---
28  2019 Explaining the decline in coronary heart disease mortality rates in Japan: Contributions of changes in risk factors and evidence-based treatments between 1980 and 2012. BMI, CHD
29  2019 FDA Sodium Reduction Targets and the Food Industry: Are There Incentives to Reformulate? Microsimulation Cost-Effectiveness Analysis. CVD, FDA, ICER, QALY
30  2019 Funding and services needed to achieve universal health coverage: applications of global, regional, and national estimates of utilisation of outpatient visits and inpatient admissions from 1990 to 2016, and unit costs from 1995 to 2016. UHC
31  2019 Global and National Consumption of Animal Source Foods for Children and Adults in 2015: Systematic Analysis of Country-Specific Nutrition Surveys Worldwide (P10-077-19). ASFs, GDD, MCH, NCDs
32  2019 Global burden of latent multidrug-resistant tuberculosis: trends and estimates based on mathematical modelling. MDR
33  2019 Global burden of melioidosis in 2015: a systematic review and data synthesis. DALYs, ESCMID
34  2019 Global Updates on Cardiovascular Disease Mortality Trends and Attribution of Traditional Risk Factors. GBD
35  2019 Global, national, and urban burdens of paediatric asthma incidence attributable to ambient NO2 pollution: estimates from global datasets. TRAP
36  2019 Global, regional and national burden of testicular cancer, 1990-2016: results from the Global Burden of Disease Study 2016. DALYs, GBD, TCa, YLDs, YLLs
37  2019 Global, regional, and country-level estimates of hepatitis C infection among people who have recently injected drugs. HCV
38  2019 Global, regional, and national burden of Alzheimer's disease and other dementias, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. BMI, GBD, YLDs, YLLs
39  2019 Global, regional, and national burden of multiple sclerosis 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. DALYs, GBD, YLLs
40  2019 Global, regional, and national burden of traumatic brain injury and spinal cord injury, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. GBD, SCI, TBI, YLDs
41  2019 Global, regional, and national estimates of pneumonia morbidity and mortality in children younger than 5 years between 2000 and 2015: a systematic analysis. ---
42  2019 Health and economic burden of antimicrobial-resistant infections in Australian hospitals: a population-based model. AMR, BSI, E. coli, UTIs
43  2019 Health disparities across the counties of Kenya and implications for policy makers, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. GBD
44  2019 Health effects of dietary risks in 195 countries, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. DALYs, NCDs
45  2019 Health gains, costs and cost-effectiveness of a population-based screening programme for abdominal aortic aneurysms. AAA
46  2019 Health Impact and Cost-Effectiveness of Sugar-Sweetened Beverage Taxes for Reducing Cancer Burden in the United States (P22-010-19). DiCOM, NHANES, QALYs, SSB
47  2019 Mapping diphtheria-pertussis-tetanus vaccine coverage in Africa, 2000-2016: a spatial and temporal modelling study. DPT
48  2019 Measuring population ageing: an analysis of the Global Burden of Disease Study 2017. DALYs, SDI
49  2019 Microscopic examination of Gram-stained smears for anogenital gonorrhoea in men who have sex with men is cost-effective: evidence from a modelling study. GSS, ICERs, MSM, QALY
50  2019 Mortality, morbidity, and hospitalisations due to influenza lower respiratory tract infections, 2017: an analysis for the Global Burden of Disease Study 2017. GBD, LRTIs
51  2019 Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. DALYs, GBD, SDI, SEVs, YLDs, YLLs
52  2019 National and sub-national exposure to ambient fine particulate matter (PM2.5) and its attributable burden of disease in Iran from 1990 to 2016. PM, PM10, YLL
53  2019 National, regional, and global levels and trends in neonatal mortality between 1990 and 2017, with scenario-based projections to 2030: a systematic analysis. NMR, SDG
54  2019 Population-based rates of hernia surgery in Ghana. ---
55  2019 Potential Country-level Health and Cost Impacts of Legalizing Domestic Sale of Vaporized Nicotine Products. NZ, QALYs
56  2019 Potential impact of a modest reduction in salt intake on blood pressure, cardiovascular disease burden and premature mortality: a modelling study. CVD, HHD, IHD
57  2019 Potential of active transport to improve health, reduce healthcare costs, and reduce greenhouse gas emissions: A modelling study. NZ, QALYs
58  2019 Prevalence and causes of blindness and vision impairment: magnitude, temporal trends and projections in South and Central Asia. MSVI, MVI
59  2019 Prevalence and causes of vision loss in East Asia in 2015: magnitude, temporal trends and projections. DR, MSVI
60  2019 Prevalence and causes of visionloss in South-east Asia and Oceania in 2015: magnitude, temporal trends and projections. MSVI, PVA
61  2019 Preventable Cancer Burden Associated With Poor Diet in the United States. ---
62  2019 Prevention of Cardiovascular Disease and Cancer Mortality by Achieving Healthy Dietary Goals for the Swedish Population: A Macro-Simulation Modelling Study. ---
63  2019 Prevention of Prescription Opioid Misuse and Projected Overdose Deaths in the United States. ---
64  2019 Reductions in child mortality by preventing spina bifida and anencephaly: Implications in achieving Target 3.2 of the Sustainable Development Goals in developing countries. FAP SBA, SDG
65  2019 Regulating health and nutrition claims in the UK using a nutrient profile model: an explorativemodelled health impact assessment. HRCs, NCD, NP, PRIME
66  2019 Subnational estimation of modern contraceptive prevalence in five sub-Saharan African countries: a Bayesian hierarchical approach. mCPR
67  2019 The burden of headache disorders in the Eastern Mediterranean Region, 1990-2016: findings from the Global Burden of Disease study 2016. DALYs, DW, EMR, GBD, TTH, YLDs
68  2019 The Burden of HIV/AIDS in Ethiopia from 1990 to 2016: Evidence from the Global Burden of Diseases 2016 Study. DALY, GBD, HIV/AIDS, MDGs, SDGs, UN, UNAIDS, VA
69  2019 The burden of injury in China, 1990-2017: findings from the Global Burden of Disease Study 2017. DALYs, GBD, SDI
70  2019 The caries-related cost and effects of a tax on sugar-sweetened beverages. SSBs
71  2019 The Estimated Economic Burden of Cancers Attributable to Suboptimal Diet in the United States (OR17-03-19). GBD, NHANES, PAFs, SEER
72  2019 The global burden of typhoid and paratyphoid fevers: a systematic analysis for the Global Burden of Disease Study 2017. DALYs, GBD
73  2019 The impact of air pollution on deaths, disease burden, and life expectancy across the states of India: the Global Burden of Disease Study 2017. DALYs, GBD, SDI
74  2019 The potential for long-term cost-effectiveness of obesity prevention interventions in the early years of life. ---
75  2019 Tracking spending on malaria by source in 106 countries, 2000-16: an economic modelling study. OOP
76  2019 Trend of fatal poisoning at national and provincial levels in Iran from 1990 to 2015. ---
77  2019 Trends and drivers of government health spending in sub-Saharan Africa, 1995-2015. ---
78  2019 Trends of Burn Injury in the United States: 1990 to 2016. DALYs, YLD
79  2019 Trends of mortality attributable to child and maternal undernutrition, overweight/obesity and dietary risk factors of non-communicable diseases in sub-Saharan Africa, 1990-2015: findings from the Global Burden of Disease Study 2015. CMU, GBD, NCD, SSA
80  2019 [Lung cancer deaths attributable to ambient PM(2.5) exposure in 2016 in China]. ASDR, DIMAQ, PAF
81  2019 [The death trend of children under 5 years old due to foreign body in airway in China from 1990 to 2017]. ---
82  2018 Abortion in Zimbabwe: A national study of the incidence of induced abortion, unintended pregnancy and post-abortion care in 2016. AICM, PAC
83  2018 Alcohol and gender gaps in life expectancy in eight Central and Eastern European countries. CEE, LE
84  2018 Alcohol use and burden for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. DALYs
85  2018 Alcohol-impaired driving in US counties, 2002-2012. BRFSS
86  2018 Assessment of the societal cost of Taenia solium in Angonia district, Mozambique. DALYs, NCC
87  2018 Burden and risk factors of diabetes and hyperglycemia in India: findings from the Global Burden of Disease Study 2016. CKD
88  2018 Burden of COPD in Nepal. DALYs, GBD, YLDs, YLLs
89  2018 Burden of disease attributable to suboptimal diet, metabolic risks and low physical activity in Ethiopia and comparison with Eastern sub-Saharan African countries, 1990-2015: findings from the Global Burden of Disease Study 2015. CMU, DALYs, GBD, SDGs, SSA, ST-GPR
90  2018 Burden of disease in Brazil, 1990-2016: a systematic subnational analysis for the Global Burden of Disease Study 2016. DALYs, HALE, LE, YLDs, YLLs
91  2018 Burden of gout in the Nordic region, 1990-2015: findings from the Global Burden of Disease Study 2015. YLDs
92  2018 Burden of Peripheral Artery Disease in Sub-Saharan Africa and the Caribbean 1990 to 2015. DALYs, HINA, PAD, SSA
93  2018 Causes of death among children aged 5-14 years in the WHO European Region: a systematic analysis for the Global Burden of Disease Study 2016. CIS
94  2018 Changes in health in Belgium, 1990-2016: a benchmarking analysis based on the global burden of disease 2016 study. AS, DALY, GBD, YLD, YLL
95  2018 Changes in the US Burden of Chronic Kidney Disease From 2002 to 2016: An Analysis of the Global Burden of Disease Study. CKD, DALYs
96  2018 Comparative risk assessment of school food environment policies and childhood diets, childhood obesity, and future cardiometabolic mortality in the United States. BMI, CMD, CRA, SSBs
97  2018 Cost effectiveness of a community based prevention and treatment of acute malnutrition programme in Mumbai slums, India. DALYs, ICDS
98  2018 Cost-effectiveness of a low-dose computed tomography screening programme for lung cancer in New Zealand. ICER, LDCT, QALYs
99  2018 Cost-Effectiveness of Mitral Valve Repair Versus Replacement for Severe Ischemic Mitral Regurgitation: A Randomized Clinical Trial From the Cardiothoracic Surgical Trials Network MR
100  2018 Crude estimates of prescription opioid-related misuse and use disorder populations towards informing intervention system need in Canada. CIs, PO